Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-17

Clinical Trial Update: Melatonin for Prevention of Radiation Induced Oral Mucositis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating melatonin for prevention of radiation-induced oral mucositis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Hams Hamed Abdelrahman | Conditions: Oral Mucositis (Ulcerative) Due to Radiation | Phase 2 | Status: COMPLETED